Prosecution Insights
Last updated: April 19, 2026
Application No. 18/030,863

RESIN COMPOSITION FOR STEREOLITHOGRAPHY

Non-Final OA §102§103
Filed
Apr 07, 2023
Examiner
ROSWELL, JESSICA MARIE
Art Unit
1767
Tech Center
1700 — Chemical & Materials Engineering
Assignee
DIC CORPORATION
OA Round
1 (Non-Final)
52%
Grant Probability
Moderate
1-2
OA Rounds
3y 7m
To Grant
88%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allow Rate
399 granted / 768 resolved
-13.0% vs TC avg
Strong +36% interview lift
Without
With
+36.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
54 currently pending
Career history
822
Total Applications
across all art units

Statute-Specific Performance

§101
0.2%
-39.8% vs TC avg
§103
55.8%
+15.8% vs TC avg
§102
15.6%
-24.4% vs TC avg
§112
16.7%
-23.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 768 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1 and 3-5 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Park et al. (KR 2019-0044315), as cited on the IDS, wherein the machine English translation is used for citation, as evidenced by Kokubo et al. (US Serial No. 2013/0082369) and Yanagase (US Patent No. 6936348). Regarding claim 1; Park et al. teaches, in a preferred embodiment, a composition for artificial tooth formation, the composition comprising bisphenol A ethoxylated dimethacrylate, diurethane dimethacrylate, triethylene glycol, and bisphenol A glycerolate dimethacrylate (instant ultraviolet curable resin A) and rutile white pigment (instant inorganic pigment B; specific gravity 4.2) [0070-0071; Ex1-2]. Park et al. teaches the white pigment has an average particle diameter of 20 to 80 nm [0039-0040]. It is the Examiner’s position that both the D50 and D90 are less than 5 microns and 20 microns, respectively (5,000 nm and 20,000 nm). Park et al. teaches the viscosity of the composition is 300 to 800 cps (mPa·s) at room temperature (25°C) using a Brookfield DV-III Rheometer RPM (shear rate: 25 / s) [0048]. Park et al. teaches the composition of the present invention is suitable for use in a three dimensional printer (i.e. stereolithography) [0020]. However it is noted that “for stereolithography” is an intended use limitation. If the body of a claim fully and intrinsically sets forth all of the limitations of the claimed invention, and the preamble merely states, for example, the purpose or intended use of the invention, rather than any distinct definition of any of the claimed invention’s limitations, then the preamble is not considered a limitation and is of no significance to claim construction. Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1305, 51 USPQ2d 1161, 1165 (Fed. Cir. 1999). See also Rowe v. Dror, 112 F.3d 473, 478, 42 USPQ2d 1550, 1553 (Fed. Cir. 1997); see MPEP §2111.02. Kokubo et al. and Yanagase provide evidence that rutile-type titanium dioxide has a specific gravity of 4.2 [Kokubo et al. 0367, 0380, 0381, 0382; Yanagase col1, line24-29]. Regarding claim 3; Park et al. teaches the preferred embodiment further comprises phenyl bis (2,4,6-triemthylbenzoyl) phosphine oxide (long wavelength photopolymerization initiator; see instant spec [0030]) as a photopolymerization initiator [0070-0071]. Regarding claim 4; Park et al. teaches the formation of an artificial tooth via 3D printing [0073]. Regarding claim 5; Park et al. does not explicitly disclose wherein the formed product has a total light transmittance of less than 60% when the total light transmittance is measured using a sample slice having a thickness of 1mm in a beam irradiation direction. The Office realizes that all the claimed effects or physical properties are not positively stated by the reference. However, the reference teaches all of the claimed reagents, claimed amounts, and substantially similar processes. According to the original specification, the cured resin composition according to the instant application (comprising a ultraviolet curable resin and an organic pigment having a specific gravity of 2.0 ≤ ρ, a D50 ≤ 5 microns, and D90 ≤ 20 microns) has a transmittance of less than 60% when the total light transmittance is measured using a sample slice having a thickness of 1 mm in a beam irradiation direction. Therefore, the claimed effects and physical properties, i.e. % transmittance, would necessarily present in a composition with all the claimed ingredients. If it is the applicants' position that this wouldn’t be the case: (1) evidence would need to be presented to support applicants' position; and (2) it would be the Offices' position that the application contains inadequate disclosure that there is no teaching as to how to obtain the claimed properties and effects with only the claimed ingredients, claimed amounts, and substantially similar processes. See In re Spada, MPEP §2112.01, I and II. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. In the alternative, claim(s) 1 and 3-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Park et al. (KR 2019-0044315), as cited on the IDS, wherein the machine English translation is used for citation, as evidenced by Kokubo et al. (US Serial No. 2013/0082369) and Yanagase (US Patent No. 6936348). Regarding claim 1; Park et al. teaches, in a preferred embodiment, a composition for artificial tooth formation, the composition comprising bisphenol A ethoxylated dimethacrylate, diurethane dimethacrylate, triethylene glycol, and bisphenol A glycerolate dimethacrylate (instant ultraviolet curable resin A) and rutile white pigment (instant inorganic pigment B; specific gravity 4.2) [0070-0071; Ex1-2]. Park et al. teaches the viscosity of the composition is 300 to 800 cps (mPa·s) at room temperature (25°C) using a Brookfield DV-III Rheometer RPM (shear rate: 25 / s) [0048]. Park et al. teaches the white pigment has an average particle diameter of 20 to 80 nm [0039-0040], however fails to teach a D50 ≤ 5 microns and D90 ≤ 20 microns. The experimental modification of this prior art in order to ascertain optimum operating conditions fails to render applicants’ claims patentable in the absence of unexpected results. See In re Aller, 105 USPQ 233; see MPEP §2144.05. At the time of filing, a person having ordinary skill in the art would have found it obvious to optimize the D50 and D90 (particle size) of the inorganic pigment, and would have been motivated to do so in order to achieve desired dispersibility in the composition, as well as desired transparency, as suggested by Park et al. [0040]. Furthermore a person of ordinary skill in the art would have found it obvious to optimize the particle size (D50 and D90), in order to have ease of printing (i.e. out of printing head) in three dimensional printing systems. Park et al. teaches the composition of the present invention is suitable for use in a three dimensional printer (i.e. stereolithography) [0020]. However it is noted that “for stereolithography” is an intended use limitation. If the body of a claim fully and intrinsically sets forth all of the limitations of the claimed invention, and the preamble merely states, for example, the purpose or intended use of the invention, rather than any distinct definition of any of the claimed invention’s limitations, then the preamble is not considered a limitation and is of no significance to claim construction. Pitney Bowes, Inc. v. Hewlett-Packard Co., 182 F.3d 1298, 1305, 51 USPQ2d 1161, 1165 (Fed. Cir. 1999). See also Rowe v. Dror, 112 F.3d 473, 478, 42 USPQ2d 1550, 1553 (Fed. Cir. 1997); see MPEP §2111.02. Kokubo et al. and Yanagase provide evidence that rutile-type titanium dioxide has a specific gravity of 4.2 [Kokubo et al. 0367, 0380, 0381, 0382; Yanagase col1, line24-29]. Regarding claim 3; Park et al. teaches the preferred embodiment further comprises phenyl bis (2,4,6-triemthylbenzoyl) phosphine oxide (long wavelength photopolymerization initiator; see instant spec [0030]) as a photopolymerization initiator [0070-0071]. Regarding claim 4; Park et al. teaches the formation of an artificial tooth via 3D printing [0073]. Regarding claim 5; Park et al. does not explicitly disclose wherein the formed product has a total light transmittance of less than 60% when the total light transmittance is measured using a sample slice having a thickness of 1mm in a beam irradiation direction. The Office realizes that all the claimed effects or physical properties are not positively stated by the reference. However, the reference teaches all of the claimed reagents, claimed amounts, and substantially similar processes. According to the original specification, the cured resin composition according to the instant application (comprising a ultraviolet curable resin and an organic pigment having a specific gravity of 2.0 ≤ ρ, a D50 ≤ 5 microns, and D90 ≤ 20 microns) has a transmittance of less than 60% when the total light transmittance is measured using a sample slice having a thickness of 1 mm in a beam irradiation direction. Therefore, the claimed effects and physical properties, i.e. % transmittance, would necessarily present in a composition with all the claimed ingredients. If it is the applicants' position that this wouldn’t be the case: (1) evidence would need to be presented to support applicants' position; and (2) it would be the Offices' position that the application contains inadequate disclosure that there is no teaching as to how to obtain the claimed properties and effects with only the claimed ingredients, claimed amounts, and substantially similar processes. See In re Spada, MPEP §2112.01, I and II. Claim(s) 2 is/are rejected under 35 U.S.C. 103 as being unpatentable over Park et al. (KR 2019-0044315), as cited on the IDS, wherein the machine English translation is used for citation, evidenced by Kokubo et al. (US Serial No. 2013/0082369) and Yanagase (US Patent No. 6936348), as applied to claim 1 above, and further in view of Lee (US Serial No. 2014/0167300). Park et al. teaches the basic claimed resin composition for stereolithography, as set forth above, with respect to claim 1. Regarding claim 2; Park et al. teaches a composition for artificial tooth formation [0002], the composition comprising bisphenol A ethoxylate dimethacrylate (EO2), however fails to teach the ethoxylated bisphenol A dimethacrylate, as required by instant claim 2. Lee teaches photocurable resin compositions, suitable for use in manufacturing artificial teeth by three dimensional printing, the compositions comprising bisphenol A dimethacrylates, such as SR348 (bisphenol A ethoxylate dimethacrylate (EO2)) and SR540 (bisphenol A ethoxylate dimethacrylate (EO4)) [0028]. Therefore, Lee teaches that bisphenol A ethoxylate dimethacrylate (EO2) and bisphenol A ethoxylate dimethacrylate (EO4) are functional equivalents for the purpose of functioning as photocurable compounds suitable for producing artificial teeth via three dimensional printing. It is prima facie obvious to substitute art-recognized functional equivalents known for the same purpose (See MPEP § 2144.06). Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to JESSICA ROSWELL whose telephone number is (571)270-5453. The examiner can normally be reached M-F 8:00 am to 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark Eashoo can be reached at 571-272-1197. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JESSICA M ROSWELL/Primary Examiner, Art Unit 1767
Read full office action

Prosecution Timeline

Apr 07, 2023
Application Filed
Jan 26, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12595357
BLACK KNOT MELANIN - A SUPER-ADDITIVE WITH UV ABSORBING AND ANTIOXIDANT PROPERTIES
2y 5m to grant Granted Apr 07, 2026
Patent 12594147
CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE LITHOGRAPHY-BASED PHOTOPOLYMERIZATION PROCESS AND METHOD OF PRODUCING CROSSLINKED POLYMERS THEREFROM
2y 5m to grant Granted Apr 07, 2026
Patent 12590213
THREE-DIMENSIONAL PRINTING WITH SUPRAMOLECULAR TEMPLATED HYDROGELS
2y 5m to grant Granted Mar 31, 2026
Patent 12565555
PHOTOCURABLE COMPOSITION, CURED PRODUCT, AND DENTAL PRODUCT
2y 5m to grant Granted Mar 03, 2026
Patent 12564649
INTERFACE MATERIAL FOR VIRTUAL REALITY INTERACTION AND PREPARATION METHOD THEREFOR
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
52%
Grant Probability
88%
With Interview (+36.5%)
3y 7m
Median Time to Grant
Low
PTA Risk
Based on 768 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month